OBJECTIVE: To examine the latent structure of a test battery currently being used in a longitudinal study of asymptomatic middle-aged adults with a parental history of Alzheimer's disease (AD) and test the invariance of the factor solution across subgroups defined by selected demographic variables and known genetic risk factors for AD. METHOD: An exploratory factor analysis (EFA) and a sequence of confirmatory factor analyses (CFA) were conducted on 24 neuropsychological measures selected to provide a comprehensive estimate of cognitive abilities most likely to be affected in preclinical AD. Once the underlying latent model was defined and the structural validity established through model comparisons, a multigroup confirmatory factor analysis model was used to test for factorial invariance across groups. RESULTS: The EFA solution revealed a factor structure consisting of five constructs: verbal ability, visuospatial ability, speed & executive function, working memory, and verbal learning & memory. The CFA models provided support for the hypothesized 5-factor structure. Results indicated factorial invariance of the model across all groups examined. CONCLUSIONS: Collectively, the results suggested a relatively strong psychometric basis for using the factor structure in clinical samples that match the characteristics of this cohort. This confirmed an invariant factor structure should prove useful in research aimed to detect the earliest cognitive signature of preclinical AD in similar middle aged cohorts. (c) 2010 APA, all rights reserved
OBJECTIVE: To examine the latent structure of a test battery currently being used in a longitudinal study of asymptomatic middle-aged adults with a parental history of Alzheimer's disease (AD) and test the invariance of the factor solution across subgroups defined by selected demographic variables and known genetic risk factors for AD. METHOD: An exploratory factor analysis (EFA) and a sequence of confirmatory factor analyses (CFA) were conducted on 24 neuropsychological measures selected to provide a comprehensive estimate of cognitive abilities most likely to be affected in preclinical AD. Once the underlying latent model was defined and the structural validity established through model comparisons, a multigroup confirmatory factor analysis model was used to test for factorial invariance across groups. RESULTS: The EFA solution revealed a factor structure consisting of five constructs: verbal ability, visuospatial ability, speed & executive function, working memory, and verbal learning & memory. The CFA models provided support for the hypothesized 5-factor structure. Results indicated factorial invariance of the model across all groups examined. CONCLUSIONS: Collectively, the results suggested a relatively strong psychometric basis for using the factor structure in clinical samples that match the characteristics of this cohort. This confirmed an invariant factor structure should prove useful in research aimed to detect the earliest cognitive signature of preclinical AD in similar middle aged cohorts. (c) 2010 APA, all rights reserved
Authors: David Bartrés-Faz; Carme Junqué; Pedro Moral; Antoni López-Alomar; Josep Sánchez-Aldeguer; Imma C Clemente Journal: J Neuropsychiatry Clin Neurosci Date: 2002 Impact factor: 2.198
Authors: L Adrienne Cupples; Lindsay A Farrer; A Dessa Sadovnick; Norman Relkin; Peter Whitehouse; Robert C Green Journal: Genet Med Date: 2004 Jul-Aug Impact factor: 8.822
Authors: C H Kawas; M M Corrada; R Brookmeyer; A Morrison; S M Resnick; A B Zonderman; D Arenberg Journal: Neurology Date: 2003-04-08 Impact factor: 9.910
Authors: D A Cahn-Weiner; E V Sullivan; P K Shear; R Fama; K O Lim; J A Yesavage; J R Tinklenberg; A Pfefferbaum Journal: J Int Neuropsychol Soc Date: 1999-09 Impact factor: 2.892
Authors: Scott M Hofer; Helen Christensen; Andrew J Mackinnon; Ailsa E Korten; Anthony F Jorm; Alexander S Henderson; Simon Easteal Journal: Psychol Aging Date: 2002-06
Authors: David A Gansler; Matthew W Jerram; Tracy D Vannorsdall; David J Schretlen Journal: Arch Clin Neuropsychol Date: 2011-10-20 Impact factor: 2.813
Authors: Burcu F Darst; Rebecca L Koscik; Bruce P Hermann; Asenath La Rue; Mark A Sager; Sterling C Johnson; Corinne D Engelman Journal: J Alzheimers Dis Date: 2015 Impact factor: 4.472
Authors: Elizabeth A Boots; Stephanie A Schultz; Rodrigo P Almeida; Jennifer M Oh; Rebecca L Koscik; Maritza N Dowling; Catherine L Gallagher; Cynthia M Carlsson; Howard A Rowley; Barbara B Bendlin; Sanjay Asthana; Mark A Sager; Bruce P Hermann; Sterling C Johnson; Ozioma C Okonkwo Journal: Arch Clin Neuropsychol Date: 2015-07-08 Impact factor: 2.813
Authors: Ozioma C Okonkwo; Guofan Xu; Jennifer M Oh; N Maritza Dowling; Cynthia M Carlsson; Catherine L Gallagher; Alex C Birdsill; Matthew Palotti; Whitney Wharton; Bruce P Hermann; Asenath LaRue; Barbara B Bendlin; Howard A Rowley; Sanjay Asthana; Mark A Sager; Sterling C Johnson Journal: Cereb Cortex Date: 2012-12-12 Impact factor: 5.357
Authors: Napatkamon Ayutyanont; Jessica B S Langbaum; Suzanne B Hendrix; Kewei Chen; Adam S Fleisher; Michel Friesenhahn; Michael Ward; Camilo Aguirre; Natalia Acosta-Baena; Lucìa Madrigal; Claudia Muñoz; Victoria Tirado; Sonia Moreno; Pierre N Tariot; Francisco Lopera; Eric M Reiman Journal: J Clin Psychiatry Date: 2014-06 Impact factor: 4.384
Authors: Rebecca L Koscik; Asenath La Rue; Erin M Jonaitis; Ozioma C Okonkwo; Sterling C Johnson; Barbara B Bendlin; Bruce P Hermann; Mark A Sager Journal: Dement Geriatr Cogn Disord Date: 2014-02-20 Impact factor: 2.959
Authors: Burcu F Darst; Rebecca L Koscik; Annie M Racine; Jennifer M Oh; Rachel A Krause; Cynthia M Carlsson; Henrik Zetterberg; Kaj Blennow; Bradley T Christian; Barbara B Bendlin; Ozioma C Okonkwo; Kirk J Hogan; Bruce P Hermann; Mark A Sager; Sanjay Asthana; Sterling C Johnson; Corinne D Engelman Journal: J Alzheimers Dis Date: 2017 Impact factor: 4.472